KPV peptide for gut and skin health: what the science actually says

What did @sally.swalling actually say?

The caption does the heavy lifting here. Sally claims KPV "acts as a potent regulator of inflammation and immune function" and lists IBS, Crohn's, colitis, eczema, dermatitis, acne, and wound healing as conditions it treats. The video itself is almost entirely a reconstitution tutorial, walking through how to mix bacteriostatic water with KPV using a syringe. She draws "2mm" of bacteriostatic water and mentions "10mm of KPV," using a larger gauge because it's "quicker." There are no verbal therapeutic claims in the actual footage, which is worth noting. The medical claims live in the caption, not the spoken content.

That distinction matters for how we evaluate this. The tutorial content is procedural. The disease treatment claims are in text. Both deserve scrutiny, but they're doing different jobs in this post.

Does the science back this up?

Partially, but the caption dramatically overstates the clinical evidence. KPV is a tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH), and there is legitimate preclinical research supporting its anti-inflammatory properties, particularly in gut tissue. The problem is that "preclinical" is doing enormous work here.

Dalmasso et al. (2008, Journal of Physiology and Pharmacology) showed KPV reduced inflammation in murine colitis models by inhibiting NF-kB signaling in intestinal epithelial cells. That's a real finding. Brzoska et al. (2008, Peptides) documented wound-healing effects in rodent models. Singh and Bhatt (2012, Peptides) explored KPV's skin anti-inflammatory effects in vitro. These are mouse studies and cell cultures. There are no published randomized controlled trials in humans for KPV as a standalone peptide therapy. Claiming it "treats" Crohn's or IBS based on murine data is a significant leap that the research does not support.

What did they get wrong (or right)?

The reconstitution procedure is mostly reasonable in principle. Using bacteriostatic water, wiping septa with alcohol, and drawing slowly are standard compounding practices. She doesn't recommend a dose verbally, which is one thing she avoided correctly.

What's wrong: the caption uses the word "treat" repeatedly for named medical conditions. That's not what the evidence shows. KPV has shown promise in preclinical models, but treating Crohn's disease or IBS requires clinical trial evidence in humans, and that evidence does not yet exist for KPV. Calling it a "potent regulator" in a consumer-facing post selling a specific product with a discount code crosses from education into promotion that isn't grounded in human clinical data.

The measurement language in the video is also imprecise. Mixing volumes described as "2mm" and "10mm" without clarifying units or concentration creates real confusion for anyone attempting to replicate this at home without medical supervision.

What should you actually know?

KPV is a research-stage peptide. It is not FDA-approved for any condition. It is not available as a regulated pharmaceutical product in Australia or the US for human use outside of compounding pharmacies operating under specific oversight. Purchasing it from a supplement vendor and self-administering based on a TikTok tutorial carries real risks: sterility, dosing errors, and unknown purity are all legitimate concerns with unregulated peptide products.

The underlying biology is genuinely interesting. Alpha-MSH derived peptides have a real mechanistic basis for anti-inflammatory activity through melanocortin receptors, particularly MC1R and MC3R. That science is worth following. But "interesting preclinical mechanism" and "proven treatment for Crohn's disease" are not the same sentence, and conflating them to sell product with a discount code is misleading regardless of how sincerely the creator believes it.

If you have IBS, Crohn's, or eczema, there are actual evidence-based treatments with human trial data. KPV may eventually join that list. It is not there yet.